SCHEMBL7058665

SCHEMBL7058665

NCCSNc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.44
CYP2D6 P10635 4/20 0.44
CYP2C19 P33261 4/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2C9 P11712 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
IDO1 P14902 3/20 0.44
PTGS2 P35354 2/20 0.44
LMNA P02545 1/20 0.44
KIF11 P52732 7/20 0.42
TSHR P16473 3/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 2/20 0.36
CTSD P07339 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CYP2A6 P11509 1/20 0.36
HTR2A P28223 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3628526 0.77 ALDH1A1 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL29008293 0.77 TDP1 (0.39) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
Hydrogen Sulfide SCHEMBL28258698 0.76 ALDH1A1 (0.41) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL14776233 0.75 TDP1 (0.46) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL7495271 0.74 ALDH1A1 (0.51) CYP2C19ALDH1A1HSD17B10SMN1; SMN2EPHX1
Hydrochloric Acid SCHEMBL28165709 0.74 ALDH1A1 (0.40) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL8525111 0.72 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2EPHX1
SCHEMBL7072380 0.71 ALDH1A1 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL6676668 0.71 TDP1 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
Fluoride SCHEMBL5698616 0.71 KCNH3 (0.40) TDP1ALDH1A1HSD17B10SMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003026666-A1 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, AS SRC KINASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed